559 related articles for article (PubMed ID: 15130128)
21. Genome sequencing analysis of Streptomyces coelicolor mutants that overcome the phosphate-depending vancomycin lethal effect.
Santos-Beneit F
BMC Genomics; 2018 Jun; 19(1):457. PubMed ID: 29898657
[TBL] [Abstract][Full Text] [Related]
22. Genes homologous to glycopeptide resistance vanA are widespread in soil microbial communities.
Guardabassi L; Agersø Y
FEMS Microbiol Lett; 2006 Jun; 259(2):221-5. PubMed ID: 16734783
[TBL] [Abstract][Full Text] [Related]
23. Kinetic comparison of the specificity of the vancomycin resistance VanSfor two response regulators, VanR and PhoB.
Fisher SL; Kim SK; Wanner BL; Walsh CT
Biochemistry; 1996 Apr; 35(15):4732-40. PubMed ID: 8664263
[TBL] [Abstract][Full Text] [Related]
24. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.
Reynolds PE; Depardieu F; Dutka-Malen S; Arthur M; Courvalin P
Mol Microbiol; 1994 Sep; 13(6):1065-70. PubMed ID: 7854121
[TBL] [Abstract][Full Text] [Related]
25. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.
van der Aart LT; Lemmens N; van Wamel WJ; van Wezel GP
Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282
[TBL] [Abstract][Full Text] [Related]
26. Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and
Gargvanshi S; Vemula H; Gutheil WG
J Bacteriol; 2021 Jul; 203(16):e0023021. PubMed ID: 34060906
[TBL] [Abstract][Full Text] [Related]
27. Vancomycin resistance in gram-positive cocci.
Courvalin P
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
[TBL] [Abstract][Full Text] [Related]
28. Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.
Pieper R; Gatlin-Bunai CL; Mongodin EF; Parmar PP; Huang ST; Clark DJ; Fleischmann RD; Gill SR; Peterson SN
Proteomics; 2006 Aug; 6(15):4246-58. PubMed ID: 16826566
[TBL] [Abstract][Full Text] [Related]
29. Binding sites of VanRB and sigma70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524.
Depardieu F; Courvalin P; Kolb A
Mol Microbiol; 2005 Jul; 57(2):550-64. PubMed ID: 15978084
[TBL] [Abstract][Full Text] [Related]
30. Rapid detection and differentiation method of VanA, VanB and VanC phenotypes in vancomycin-resistant enterococci.
Hanaki H; Yamaguchi Y; Nomura S; Nagayama A; Sunakawa K
Int J Antimicrob Agents; 2004 May; 23(5):502-5. PubMed ID: 15120731
[TBL] [Abstract][Full Text] [Related]
31. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
Togneri A; Lopardo H; Corso A
Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
[TBL] [Abstract][Full Text] [Related]
32. Glycopeptide-resistance transferability from vancomycin-resistant enterococci of human and animal source to Listeria spp.
de Niederhäusern S; Sabia C; Messi P; Guerrieri E; Manicardi G; Bondi M
Lett Appl Microbiol; 2004; 39(6):483-9. PubMed ID: 15548299
[TBL] [Abstract][Full Text] [Related]
33. Putative VanRS-like two-component regulatory system associated with the inducible glycopeptide resistance cluster of Paenibacillus popilliae.
Fraimow H; Knob C; Herrero IA; Patel R
Antimicrob Agents Chemother; 2005 Jul; 49(7):2625-33. PubMed ID: 15980329
[TBL] [Abstract][Full Text] [Related]
34. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174.
Arias CA; Courvalin P; Reynolds PE
Antimicrob Agents Chemother; 2000 Jun; 44(6):1660-6. PubMed ID: 10817725
[TBL] [Abstract][Full Text] [Related]
35. Activation of the L,D-transpeptidation peptidoglycan cross-linking pathway by a metallo-D,D-carboxypeptidase in Enterococcus faecium.
Sacco E; Hugonnet JE; Josseaume N; Cremniter J; Dubost L; Marie A; Patin D; Blanot D; Rice LB; Mainardi JL; Arthur M
Mol Microbiol; 2010 Feb; 75(4):874-85. PubMed ID: 20025663
[TBL] [Abstract][Full Text] [Related]
36. Specificity of induction of the vanA and vanB operons in vancomycin-resistant enterococci by telavancin.
Hill CM; Krause KM; Lewis SR; Blais J; Benton BM; Mammen M; Humphrey PP; Kinana A; Janc JW
Antimicrob Agents Chemother; 2010 Jul; 54(7):2814-8. PubMed ID: 20404117
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.
Weigel LM; Clewell DB; Gill SR; Clark NC; McDougal LK; Flannagan SE; Kolonay JF; Shetty J; Killgore GE; Tenover FC
Science; 2003 Nov; 302(5650):1569-71. PubMed ID: 14645850
[TBL] [Abstract][Full Text] [Related]
38. The vanG glycopeptide resistance operon from Enterococcus faecalis revisited.
Depardieu F; Bonora MG; Reynolds PE; Courvalin P
Mol Microbiol; 2003 Nov; 50(3):931-48. PubMed ID: 14617152
[TBL] [Abstract][Full Text] [Related]
39. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance.
Hashimoto Y; Tanimoto K; Ozawa Y; Murata T; Ike Y
FEMS Microbiol Lett; 2000 Apr; 185(2):247-54. PubMed ID: 10754256
[TBL] [Abstract][Full Text] [Related]
40. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.
Lee JG; Sagui C; Roland C
J Phys Chem B; 2005 Nov; 109(43):20588-96. PubMed ID: 16853665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
